Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 10, 2007, Pages 641-646

  Wang, Teng ^a   Dong, Ying ^a   Wang, Li Chen ^a   Chen, Zhen ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

3(2H) pyridazinones, cardiotonic activity, synthesis; Cardiotonic agents

Indexed keywords

5 CHLORO 2 NITRO N [4 (4 METHYL 6 OXO 1,4,5,6 TETRAHYDROPYRIDAZIN 3 YL)PHENYL]BENZAMIDE; BENZENE DERIVATIVE; CARDIOTONIC AGENT; LEVOSIMENDAN; PYRIDAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HEART CONTRACTION; INFRARED SPECTROSCOPY; ISOLATED HEART; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; TOAD;

EID: 35948964749     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296662     Document Type: Article

References (8)

1. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linkers DT, Hofman A. Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J. 1999;20:447-455.
2. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of CHF. Eur Heart J. 2001;22:1527-1560.
3. Cleland JG, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail. 1999;1:229-241.
4. Sircar I, Duell BL, Bobowski G, Bristol JA. Evans DB. Synthesis and structure-activity relationships of 4, 5- dihydro-6- [4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents. J Med Chem. 1985;28:1405-1413.
5. Robertson DW, Krushinski JH, Beedle EE, Wyss, V, Pollock GD, Wilson H. Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5′-(1, 4, 5, 6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane-1, 3′-[3H]indol]-2′(1′H)-ones. J Med Chem. 1987;30:824-829.
6. Weishaar RE, Cain MH, Bristol JA. A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem. 1985;28:537-545.
7. Endoh M. Mechanisms of action of novel cardiotonic agents. J Cardiovasc Pharmacol. 2002;40:323-338.
8. Hai-Jun Zhou, Shi-xian Deng. Pharmaceutical experiments on isolated heart preparations. In: Shu-Yun Xu, Ru-Lian Bian, Xiu Chen, eds. The methodology of pharmaceutical experiment. Beijing: People's Medical Publishing House; 1991. p. 863-864.